Abstract
The aim of the present review is to portray a concise account of the isolation, chemistry and bioactivity of azoles-containing natural products discovered during the last few years with a special emphasis on those compounds with a new structural motif. The material will be classified on a structural basis starting from simple monocycle-containing open chain molecules to the complex polyazole-containing, medium- and large-sized macrolides. Details on the isolation procedures and on the biological targets and activities will be given. Molecules in which azoles are present as part of standard amino-acids and nucleobases will not be considered.
Keywords: Alkaloids, azoles, bioactivity, isolation, natural products, structural determination, azole containing alkaloids, Cruciferous, OXAZOLE ALKALOIDS, Neopeltolide, NCI-ADR-RES human ovarian sarcoma, P388 murine leukemia cell lines, EtOAc, Candida albicans, C. glabrata, Cryptococcus neoformans, Thiazole-containing Macrolides, Cystobacter violaceus, Sorangium cellulosum, Mycobacterium tuberculosis, prochloron, Microcystis aeruginosa, HR-NMR, Marfey's method, Thamnocephalus platyurus, Amycolatopsis fastidiosa, Staphylococcus aureus, Oscillatoria, Actinoplanes philippinensis, 1D TOCSY, HRESIFT-MS/MS, Didemnum molle, Plasmodium falciparum, Leishmania domovani, Pyrrole Alkaloids, NADH-ubiquinone oxidoreductase, bisdehydrostemoninine, Halogenated Pyrrole Alkaloids, Axinella vaceleti, Stylissa caribica, Stylissa flabellate, Axinella verrucosa, Axinella damicornis, carteramine A, Stylissa carteri, Indole Alkaloids, Eunicella granulate, camelaxin, Leptosphaeria maculans, Sclerotinia sclerotiorum, Rhizoctonia solani, Brassica rapa, Albugo candida, phytoalexins, Aspergillus Variecolor, Cephalanceropsis gracilis, Nauclea officinalis, 18-oxotryprostatin A, 14-hydroxyterezine D, monomarginine, 9-deacetoxyfumigaclavine C, bisnicalaterine A, ELISA, Eusynstyela latericius, nNOS, PPDK, Isonitrile-Indole Alkaloids, Azadirachta indica, Hapalindole T, 12-epi-Hapalindole J isonitrile, ambiguine H isonitrile, ambiguine I isonitrile, ambiguines K, –, O, b-Carbolines, Nodularia harveyana, brunnein A, Eudistomin Y6, zamamidines A, Trichophyton mentagrophytes, Tabernaemontana elegans, CARBAZOLE ALKALOIDS, murrafoline-I, PYRROLOACRIDINE ALKALOIDS, Plakinidine A, plakinidine E, naamidines H, Bistellettazole A
Current Bioactive Compounds
Title: Current Bioactive Azole-Containing Natural Products
Volume: 6 Issue: 4
Author(s): Gianfranco Fontana
Affiliation:
Keywords: Alkaloids, azoles, bioactivity, isolation, natural products, structural determination, azole containing alkaloids, Cruciferous, OXAZOLE ALKALOIDS, Neopeltolide, NCI-ADR-RES human ovarian sarcoma, P388 murine leukemia cell lines, EtOAc, Candida albicans, C. glabrata, Cryptococcus neoformans, Thiazole-containing Macrolides, Cystobacter violaceus, Sorangium cellulosum, Mycobacterium tuberculosis, prochloron, Microcystis aeruginosa, HR-NMR, Marfey's method, Thamnocephalus platyurus, Amycolatopsis fastidiosa, Staphylococcus aureus, Oscillatoria, Actinoplanes philippinensis, 1D TOCSY, HRESIFT-MS/MS, Didemnum molle, Plasmodium falciparum, Leishmania domovani, Pyrrole Alkaloids, NADH-ubiquinone oxidoreductase, bisdehydrostemoninine, Halogenated Pyrrole Alkaloids, Axinella vaceleti, Stylissa caribica, Stylissa flabellate, Axinella verrucosa, Axinella damicornis, carteramine A, Stylissa carteri, Indole Alkaloids, Eunicella granulate, camelaxin, Leptosphaeria maculans, Sclerotinia sclerotiorum, Rhizoctonia solani, Brassica rapa, Albugo candida, phytoalexins, Aspergillus Variecolor, Cephalanceropsis gracilis, Nauclea officinalis, 18-oxotryprostatin A, 14-hydroxyterezine D, monomarginine, 9-deacetoxyfumigaclavine C, bisnicalaterine A, ELISA, Eusynstyela latericius, nNOS, PPDK, Isonitrile-Indole Alkaloids, Azadirachta indica, Hapalindole T, 12-epi-Hapalindole J isonitrile, ambiguine H isonitrile, ambiguine I isonitrile, ambiguines K, –, O, b-Carbolines, Nodularia harveyana, brunnein A, Eudistomin Y6, zamamidines A, Trichophyton mentagrophytes, Tabernaemontana elegans, CARBAZOLE ALKALOIDS, murrafoline-I, PYRROLOACRIDINE ALKALOIDS, Plakinidine A, plakinidine E, naamidines H, Bistellettazole A
Abstract: The aim of the present review is to portray a concise account of the isolation, chemistry and bioactivity of azoles-containing natural products discovered during the last few years with a special emphasis on those compounds with a new structural motif. The material will be classified on a structural basis starting from simple monocycle-containing open chain molecules to the complex polyazole-containing, medium- and large-sized macrolides. Details on the isolation procedures and on the biological targets and activities will be given. Molecules in which azoles are present as part of standard amino-acids and nucleobases will not be considered.
Export Options
About this article
Cite this article as:
Fontana Gianfranco, Current Bioactive Azole-Containing Natural Products, Current Bioactive Compounds 2010; 6 (4) . https://dx.doi.org/10.2174/157340710793237290
DOI https://dx.doi.org/10.2174/157340710793237290 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Aspects of Natural and Modified Vinca Alkaloids
Current Medicinal Chemistry - Anti-Cancer Agents Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology Large-Scale Production Means for the Manufacturing of Lentiviral Vectors
Current Gene Therapy Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry Control of Protein Synthesis in Malignant Transformation - the Role of eIF4E and the eIF4E Binding Proteins in the Regulation of Apoptosis
Current Cancer Therapy Reviews The HIV-1 Tat Protein: A Multifaceted Target for Novel Therapeutic Opportunities
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Emerging Therapies in Chronic Myeloid Leukemia
Current Cancer Drug Targets Toxicogenomics to Evaluate Endocrine Disrupting Effects of Environmental Chemicals Using the Zebrafish Model
Current Genomics Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Chemical and physical factors influencing the dynamics of differentiation in embryonic stem cells
Current Stem Cell Research & Therapy Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
CNS & Neurological Disorders - Drug Targets Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Current Signal Transduction Therapy Humoral Immunity in HIV-1 Exposure: Cause or Effect of HIV Resistance?
Current HIV Research Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy
Current Drug Metabolism Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
Current Cancer Drug Targets